Kyung Nam PharmLtd Balance Sheet Health
Financial Health criteria checks 5/6
Kyung Nam PharmLtd has a total shareholder equity of ₩87.0B and total debt of ₩50.5B, which brings its debt-to-equity ratio to 58.1%. Its total assets and total liabilities are ₩159.6B and ₩72.6B respectively.
Key information
58.1%
Debt to equity ratio
₩50.53b
Debt
Interest coverage ratio | n/a |
Cash | ₩33.68b |
Equity | ₩86.96b |
Total liabilities | ₩72.64b |
Total assets | ₩159.61b |
Financial Position Analysis
Short Term Liabilities: A053950's short term assets (₩65.4B) exceed its short term liabilities (₩62.9B).
Long Term Liabilities: A053950's short term assets (₩65.4B) exceed its long term liabilities (₩9.8B).
Debt to Equity History and Analysis
Debt Level: A053950's net debt to equity ratio (19.4%) is considered satisfactory.
Reducing Debt: A053950's debt to equity ratio has increased from 17.7% to 58.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A053950 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A053950 has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 12.9% each year.